Lillian Werner

6.1k total citations
126 papers, 2.4k citations indexed

About

Lillian Werner is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Lillian Werner has authored 126 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 32 papers in Surgery and 32 papers in Molecular Biology. Recurrent topics in Lillian Werner's work include Prostate Cancer Treatment and Research (32 papers), Chronic Lymphocytic Leukemia Research (30 papers) and Bladder and Urothelial Cancer Treatments (28 papers). Lillian Werner is often cited by papers focused on Prostate Cancer Treatment and Research (32 papers), Chronic Lymphocytic Leukemia Research (30 papers) and Bladder and Urothelial Cancer Treatments (28 papers). Lillian Werner collaborates with scholars based in United States, Spain and United Kingdom. Lillian Werner's co-authors include Toni K. Choueiri, Philip W. Kantoff, Donna Neuberg, Joaquim Bellmunt, Sabina Signoretti, Meredith M. Regan, Stephanie A. Mullane, Gordon J. Freeman, Jennifer R. Brown and F. Stephen Hodi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Lillian Werner

123 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lillian Werner United States	29	891	823	711	558	520	126	2.4k
Marco Pizzi Italy	28	385 0.4×	463 0.6×	910 1.3×	522 0.9×	286 0.6×	124	2.2k
Syma Iqbal United States	29	993 1.1×	2.0k 2.4×	901 1.3×	679 1.2×	194 0.4×	129	3.1k
Christian Scheffold United States	25	1.0k 1.2×	1.0k 1.3×	900 1.3×	176 0.3×	277 0.5×	75	2.3k
John W. Moroney United States	19	438 0.5×	874 1.1×	656 0.9×	172 0.3×	569 1.1×	49	2.5k
Wael A. Harb United States	23	759 0.9×	1.4k 1.7×	923 1.3×	125 0.2×	294 0.6×	118	2.5k
Randeep Sangha Canada	23	542 0.6×	1.3k 1.6×	590 0.8×	376 0.7×	288 0.6×	72	2.3k
Nicole Mentens Belgium	22	619 0.7×	449 0.5×	766 1.1×	263 0.5×	360 0.7×	33	2.4k
Celine Wilke United States	8	905 1.0×	960 1.2×	777 1.1×	114 0.2×	406 0.8×	20	2.2k
Céline Callens France	27	480 0.5×	670 0.8×	1.0k 1.5×	217 0.4×	153 0.3×	83	2.2k
Charlotte H. Ahern United States	22	541 0.6×	756 0.9×	798 1.1×	173 0.3×	194 0.4×	42	2.0k

Countries citing papers authored by Lillian Werner

Since Specialization

Citations

This map shows the geographic impact of Lillian Werner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lillian Werner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lillian Werner more than expected).

Fields of papers citing papers by Lillian Werner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lillian Werner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lillian Werner. The network helps show where Lillian Werner may publish in the future.

Co-authorship network of co-authors of Lillian Werner

This figure shows the co-authorship network connecting the top 25 collaborators of Lillian Werner. A scholar is included among the top collaborators of Lillian Werner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lillian Werner. Lillian Werner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Werner, Lillian, Elisabeth Werner Rönnerman, Constantina Mateoiu, et al.. (2025). Diagnostic and prognostic biomarkers associated with histotype in advanced epithelial ovarian cancer. Scientific Reports. 15(1). 37171–37171.

McKay, Rana R., Lucia Kwak, Jett Crowdis, et al.. (2021). Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance. Clinical Cancer Research. 27(13). 3610–3619. 21 indexed citations

Regan, Meredith M., Opeyemi A. Jegede, Charlene Mantia, et al.. (2020). 713P Treatment-free survival, with and without toxicity, after immuno-oncology vs targeted therapy for advanced renal cell carcinoma (aRCC): 42-month results of CheckMate 214. Annals of Oncology. 31. S561–S561. 9 indexed citations

McKay, Rana R., Lillian Werner, Atish D. Choudhury, et al.. (2018). Evaluating a Video-Based, Personalized Webpage in Genitourinary Oncology Clinical Trials: A Phase 2 Randomized Trial. Journal of Medical Internet Research. 21(5). e12044–e12044. 2 indexed citations

Murad, Joana, Susanne H.C. Baumeister, Lillian Werner, et al.. (2018). Manufacturing development and clinical production of NKG2D chimeric antigen receptor–expressing T cells for autologous adoptive cell therapy. Cytotherapy. 20(7). 952–963. 46 indexed citations

Chen, Evan C., Gabriela Hobbs, Ashley Perry, et al.. (2017). The Impact of Antimicrobial Prophylaxis during Induction Chemotherapy for Acute Myeloid Leukemia in the Current Era. Blood. 130. 2586–2586. 1 indexed citations

Sevillano, Elena, Lillian Werner, Dominick Bossé, et al.. (2017). Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non–Lymph Node Distant Metastasis. Clinical Genitourinary Cancer. 15(6). e1089–e1094. 4 indexed citations

McKay, Rana R., Lillian Werner, Elahe A. Mostaghel, et al.. (2016). A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 23(4). 935–945. 28 indexed citations

Bellmunt, Joaquim, Chensheng W. Zhou, Stephanie A. Mullane, et al.. (2016). Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy. British Journal of Cancer. 115(1). 12–19. 8 indexed citations

10.

Bellmunt, Joaquim, Stephanie A. Mullane, Lillian Werner, et al.. (2015). Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinoma. Annals of Oncology. 26(4). 812–817. 229 indexed citations

11.

Mullane, Stephanie A., Lillian Werner, Elizabeth A. Guancial, et al.. (2015). Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma. Clinical Genitourinary Cancer. 14(4). 352–359. 31 indexed citations

12.

Brown, Jennifer R., Bethany Tesar, Lijian Yu, et al.. (2015). Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia. Leukemia & lymphoma. 56(12). 3336–3342. 31 indexed citations

13.

Muralidhar, Vinayak, Meredith M. Regan, Lillian Werner, et al.. (2015). Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center. Clinical Genitourinary Cancer. 14(4). e299–e305. 8 indexed citations

14.

Margalit, Danielle N., Kristina M. Jordahl, Lillian Werner, et al.. (2015). GermLine Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes After Radiation Therapy for Prostate Cancer: Results of a Test and Validation Set Analysis. Clinical Genitourinary Cancer. 13(4). 370–377.e1. 8 indexed citations

15.

Nan, Hongmei, Teppei Morikawa, Miia Suuriniemi, et al.. (2013). Aspirin Use, 8q24 Single Nucleotide Polymorphism rs6983267, and Colorectal Cancer According to CTNNB1 Alterations. JNCI Journal of the National Cancer Institute. 105(24). 1852–1861. 51 indexed citations

16.

Brown, Jennifer R., Megan Hanna, Bethany Tesar, et al.. (2012). Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 18(14). 3791–3802. 59 indexed citations

17.

Hanna, Megan, Bethany Tesar, Lillian Werner, et al.. (2012). Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia. DSpace@MIT (Massachusetts Institute of Technology). 3 indexed citations

18.

Amrein, Philip C., Eyal C. Attar, Tak Takvorian, et al.. (2011). Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia. Clinical Cancer Research. 17(9). 2977–2986. 100 indexed citations

19.

Pomerantz, Mark M., Lillian Werner, Wanling Xie, et al.. (2011). Association of Prostate Cancer Risk Loci with Disease Aggressiveness and Prostate Cancer–Specific Mortality. Cancer Prevention Research. 4(5). 719–728. 32 indexed citations

20.

Singh, Harshabad, Lillian Werner, Daniel J. DeAngelo, et al.. (2011). Comparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal acute myeloid leukemia (CN‐AML) and FLT3ITD. American Journal of Hematology. 86(7). 625–627. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact